Neoadjuvant nivolumab in early-stage non–small cell lung cancer (NSCLC): Five-year outcomes.

出版年份 2022 全文链接

标题

作者

关键词

出版物

Volume 40, Issue 16_suppl, Pages 8537-8537

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2022-06-07

DOI

10.1200/jco.2022.40.16_suppl.8537

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started